SCHEMBL5885169

SCHEMBL5885169

ClCc1ccc(Cc2ccc(CCl)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.47
ALDH1A1 P00352 4/20 0.47
TSHR P16473 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
ESR1 P03372 1/20 0.47
ESR2 Q92731 1/20 0.47
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CALM1 P0DP23 1/20 0.44
MAPK1 P28482 1/20 0.41
HPGD P15428 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 1/20 0.38
CYP2C9 P11712 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TASP1 Q9H6P5 1/20 0.38
KMT2A Q03164 1/20 0.38
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11323181 1.00 CYP3A4 (0.47) CYP3A4ALDH1A1TSHRTDP1ESR1
SCHEMBL97582 0.89 CA1 (0.52) CYP3A4ALDH1A1TSHRTDP1ESR1
SCHEMBL24715430 0.88 CALM1 (0.67) ALDH1A1CA1CA2CALM1CYP2C9
SCHEMBL8992968 0.88 IDO1 (0.48) ALDH1A1ESR1ESR2CA1CA2
SCHEMBL4426841 0.88 CALM1 (0.67) ALDH1A1CA1CA2CALM1CYP2C9
SCHEMBL8993222 0.86 IDO1 (0.46) CYP3A4ALDH1A1TSHRTDP1ESR1
SCHEMBL10565351 0.86 TAAR1 (0.43) CYP3A4ALDH1A1TSHRTDP1ESR1
SCHEMBL10564566 0.86 IDO1 (0.46) CYP3A4ALDH1A1TSHRTDP1ESR1
SCHEMBL5511243 0.80 SRD5A2 (0.50) ALDH1A1KMT2AKDM4ELTA4HIDH1
SCHEMBL9161636 0.80 LOXL2 (0.54) ALDH1A1CA2CA6IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4259460-A BLENDS OF POLYMERS OF VINYL CHLORIDE, ACRYLONITRILE-BUTADIENE, AND BUTADIENE-STYRENE-TERTIARY AMINE POLYSAR LIMITED (CA) 1981-03-31 US claimed
CN-110669219-B Sulfur-containing polymer and preparation method and application thereof 东北师范大学 2021-05-18 CN disclosed
CN-110669219-A Sulfur-containing polymer and preparation method and application thereof 东北师范大学 2020-01-10 CN disclosed
US-7030171-B2 Process for producing vinyl polymer having functional group at end and vinyl polymer having functional group at end SEKISUI CHEMICAL CO., LTD. (JP) 2006-04-18 US disclosed
EP-1311499-B1 BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS ORTHO MCNEIL PHARM INC (US) 2006-04-12 EP disclosed
US-20040092619-A1 Process for producing vinyl polymer having functional group at end and vinyl polymer having functional group at end WAKIYA TAKESHI (JP) 2004-05-13 US disclosed
US-6693142-B1 POLYMERIZATION REACTION OF VINYL MONOMERS IN PRESENCE OF HALOGEN COMPOUND AND SUBSTITUTING WITH SUCH AS HYDROXYL, AMINO, VINYL OR SILYL GROUPS SEKISUI CHEMICAL CO., LTD. (JP) 2004-02-17 US disclosed
US-6638967-B2 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine ORTHO-MCNEIL PHAMRACEUTICAL, INC. 2003-10-28 US disclosed
EP-1311499-A2 BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS Ortho-McNeil Pharmaceutical, Inc. (US) 2003-05-21 EP disclosed
EP-1243599-A1 PROCESS FOR PRODUCING VINYL POLYMER HAVING FUNCTIONAL GROUP AT END AND VINYL POLYMER HAVING FUNCTIONAL GROUP AT END SEKISUI CHEMICAL CO., LTD. (JP) 2002-09-25 EP disclosed
US-20020037896-A1 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine ORTHO MCNEIL PHARMACEUTICAL, INC. 2002-03-28 US disclosed
WO-2002012224-A2 BICYCLIC COMPOUNDS AS H3 RECEPTOR LIGANDS ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2002-02-14 WO disclosed
EP-0696585-B1 NOVEL BISOXADIAZOLIDINE DERIVATIVE YAMANOUCHI PHARMA CO LTD (JP) 1998-12-16 EP disclosed
US-5643931-A ANTIDIABETIC AGENTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0696585-A1 NOVEL BISOXADIAZOLIDINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1996-02-14 EP disclosed
US-4259460-A BLENDS OF POLYMERS OF VINYL CHLORIDE, ACRYLONITRILE-BUTADIENE, AND BUTADIENE-STYRENE-TERTIARY AMINE POLYSAR LIMITED (CA) 1981-03-31 US disclosed
US-4130579-A Bis(2-methyl-2-cyanopropyl) aromatics E. I. DU PONT DE NEMOURS AND COMPANY (US) 1978-12-19 US disclosed
US-3947471-A CHROMOGENIC SUMITOMO CHEMICAL COMPANY, LTD. (JA) 1976-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020037896-A1 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine HRH4, HRH3, HRH2 CYP3A4 1347/4885ALDH1A1 1225/4885TSHR 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.